FEBS Open Bio
(Jul 2020)
Modeling atrial fibrosis in vitro—Generation and characterization of a novel human atrial fibroblast cell line
Stephan R. Künzel,
Johanna S. E. Rausch,
Charlotte Schäffer,
Maximilian Hoffmann,
Karolina Künzel,
Erik Klapproth,
Theresa Kant,
Natalie Herzog,
Jan‐Heiner Küpper,
Kristina Lorenz,
Svenja Dudek,
Ramona Emig,
Ursula Ravens,
Eva A. Rog‐Zielinska,
Rémi Peyronnet,
Ali El‐Armouche
Affiliations
Stephan R. Künzel
Institute of Pharmacology and Toxicology Faculty of Medicine Carl Gustav Carus Technische Universität Dresden Dresden Germany
Johanna S. E. Rausch
Institute of Pharmacology and Toxicology Faculty of Medicine Carl Gustav Carus Technische Universität Dresden Dresden Germany
Charlotte Schäffer
Institute of Pharmacology and Toxicology Faculty of Medicine Carl Gustav Carus Technische Universität Dresden Dresden Germany
Maximilian Hoffmann
Institute of Pharmacology and Toxicology Faculty of Medicine Carl Gustav Carus Technische Universität Dresden Dresden Germany
Karolina Künzel
Institute of Pharmacology and Toxicology Faculty of Medicine Carl Gustav Carus Technische Universität Dresden Dresden Germany
Erik Klapproth
Institute of Pharmacology and Toxicology Faculty of Medicine Carl Gustav Carus Technische Universität Dresden Dresden Germany
Theresa Kant
Institute of Pharmacology and Toxicology Faculty of Medicine Carl Gustav Carus Technische Universität Dresden Dresden Germany
Natalie Herzog
Institute of Biotechnology Brandenburg University of Technology Cottbus‐Senftenberg Senftenberg Germany
Jan‐Heiner Küpper
Institute of Biotechnology Brandenburg University of Technology Cottbus‐Senftenberg Senftenberg Germany
Kristina Lorenz
Institute of Pharmacology and Toxicology University of Würzburg Würzburg Germany
Svenja Dudek
Institut für Experimentelle Kardiovaskuläre Medizin Universitäts Herzzentrum, Freiburg Bad ‐ Krozingen Freiburg im Breisgau Germany
Ramona Emig
Institut für Experimentelle Kardiovaskuläre Medizin Universitäts Herzzentrum, Freiburg Bad ‐ Krozingen Freiburg im Breisgau Germany
Ursula Ravens
Institut für Experimentelle Kardiovaskuläre Medizin Universitäts Herzzentrum, Freiburg Bad ‐ Krozingen Freiburg im Breisgau Germany
Eva A. Rog‐Zielinska
Institut für Experimentelle Kardiovaskuläre Medizin Universitäts Herzzentrum, Freiburg Bad ‐ Krozingen Freiburg im Breisgau Germany
Rémi Peyronnet
Institut für Experimentelle Kardiovaskuläre Medizin Universitäts Herzzentrum, Freiburg Bad ‐ Krozingen Freiburg im Breisgau Germany
Ali El‐Armouche
Institute of Pharmacology and Toxicology Faculty of Medicine Carl Gustav Carus Technische Universität Dresden Dresden Germany
DOI
https://doi.org/10.1002/2211-5463.12896
Journal volume & issue
Vol. 10,
no. 7
pp.
1210
– 1218
Abstract
Read online
Atrial fibrillation (AF) is regularly accompanied by cardiac fibrosis and concomitant heart failure. Due to the heterogeneous nature and complexity of fibrosis, the knowledge about the underlying mechanisms is limited, which prevents effective pharmacotherapy. A deeper understanding of cardiac fibroblasts is essential to meet this need. We previously described phenotypic and functional differences between atrial fibroblasts from patients in sinus rhythm and with AF. Herein, we established and characterized a novel human atrial fibroblast line, which displays typical fibroblast morphology and function comparable to primary cells but with improved proliferation capacity and low spontaneous myofibroblast differentiation. These traits make our model suitable for the study of fibrosis mechanisms and for drug screening aimed at developing effective antifibrotic pharmacotherapy.
Keywords
WeChat QR code
Close